EUVIMEDEUVIMED entdecken
Crossref

Discovery of N -Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma

Guangwei Cui, Yuhang Fan, Yue Yang, Yiwen Ma, Haiyang Deng, Pan Wang, Yuxin Zhu, Jian Li iD, Jinlian Wei, Yongqiang Zhang iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c01786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Guangwei Cui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, and School of Pharmacy, …. Hauptthemen laut MEDLINE: Glioblastoma, Noscapine, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for new and effective chemotherapeutic agents for the treatment of glioblastoma (GBM) represents an unmet need in drug discovery. Herein, a class of novel N-trifluoromethylated noscapines has been disclosed. Among them, 9'-bromo-N-trifluoromethyl noscapine 15c displayed superior in vitro anti-GBM potency. Unexpectedly, in contrast with the general N-trifluoromethyl amines, these compounds exhibited good hydrolytic stability and further investigation of this distinct stability revealed a novel strategy for the structure modification of tetrahydroisoquinoline alkaloids, where N-methyl could be bioisosterically replaced with trifluoromethyl. Furthermore, 15c showed excellent BBB permeability and good in vivo anti-GBM activity and could efficiently suppress the migration of GBM cells, while no apparent toxicity was observed, thus representing an attractive lead for further drug discovery. Further mechanistic studies revealed that 15c exhibited an ability to induce G2/M-phase arrest in GBM cells associated with the disruption of tubulin polymerization, which is consistent with the mechanism of action of noscapine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNoscapineAntineoplastic AgentsHumansAnimalsCell Line, TumorDrug DiscoveryStructure-Activity RelationshipMiceCell MovementDrug Screening Assays, AntitumorCell ProliferationBrain NeoplasmsBlood-Brain BarrierMice, Nude

Substanzen

NoscapineAntineoplastic Agents

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, and School of Pharmacy, East China University of Science and Technology, Shanghai 200237, P. R…
  • State Key Laboratory of Bioreactor Engineering, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Key Laboratory…

ORCID-Profile: Jian Li, Yongqiang Zhang

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Cui, G., Fan, Y., Yang, Y., Ma, Y., Deng, H., Wang, P., Zhu, Y., Li, J., Wei, J., & Zhang, Y. (2025). Discovery of N -Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01786

Vancouver

Cui G, Fan Y, Yang Y, Ma Y, Deng H, Wang P, et al. Discovery of N -Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01786

BibTeX
@article{Cui2025,
  author = {Cui, Guangwei and Fan, Yuhang and Yang, Yue and Ma, Yiwen and Deng, Haiyang and Wang, Pan and Zhu, Yuxin and Li, Jian and Wei, Jinlian and Zhang, Yongqiang},
  title = {Discovery of N -Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c01786}
}
Kostenlos starten →